This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (571) JMIR Theme Issue: COVID-19 Special Issue (2452) Outbreak and Pandemic Preparedness and Management (1727) Infectious Diseases (non-STD/STI) (1575) Neurology and Neurosciences (185) Chronic Conditions (270) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1517) Imaging Informatics (193) Pulmonology, COPD (143) JMH Theme Issue: COVID-19 and Mental Health: Impact and Interventions (383)

Published on in Vol 10, No 11 (2021): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/30259, first published .
Longitudinal Neurocognitive and Pulmonological Profile of Long COVID-19: Protocol for the COVIMMUNE-Clin Study

Longitudinal Neurocognitive and Pulmonological Profile of Long COVID-19: Protocol for the COVIMMUNE-Clin Study

Longitudinal Neurocognitive and Pulmonological Profile of Long COVID-19: Protocol for the COVIMMUNE-Clin Study

Authors of this article:

Catherine N Widmann1, 2 Author Orcid Image ;   Michelle Wieberneit1 Author Orcid Image ;   Luzie Bieler1 Author Orcid Image ;   Sarah Bernsen2, 3 Author Orcid Image ;   Robin Gräfenkämper1, 4 Author Orcid Image ;   Frederic Brosseron2 Author Orcid Image ;   Carsten Schmeel5 Author Orcid Image ;   Pawel Tacik2, 3 Author Orcid Image ;   Dirk Skowasch6 Author Orcid Image ;   Alexander Radbruch5 Author Orcid Image ;   Michael T Heneka2, 3 Author Orcid Image
Article Authors Cited by (10) Tweetations (45) Metrics Author Video

Journals

  1. Maity S, Mayer M, Shu Q, Linh H, Bao D, Blair R, He Y, Lyon C, Hu T, Fischer T, Fan J. Cerebrospinal Fluid Protein Markers Indicate Neuro-Damage in SARS-CoV-2-Infected Nonhuman Primates. Molecular & Cellular Proteomics 2023;22(4):100523 View
  2. Erickson M, Logsdon A, Rhea E, Hansen K, Holden S, Banks W, Smith J, German C, Farr S, Morley J, Weaver R, Hirsch A, Kovac A, Kontsekova E, Baumann K, Omer M, Raber J. Blood-brain barrier penetration of non-replicating SARS-CoV-2 and S1 variants of concern induce neuroinflammation which is accentuated in a mouse model of Alzheimer’s disease. Brain, Behavior, and Immunity 2023;109:251 View
  3. Manu P. Post-COVID Fatigue: Functional Brain Imaging and Cognitive Testing. American Journal of Therapeutics 2022;29(1):e85 View
  4. Demeter S. Pulmonary Manifestations of “Long COVID” (Post–COVID-19). Guides Newsletter 2022;27(6):16 View
  5. Rothstein T. Cortical Grey matter volume depletion links to neurological sequelae in post COVID-19 “long haulers”. BMC Neurology 2023;23(1) View
  6. Llana T, Mendez M, Zorzo C, Fidalgo C, Juan M, Mendez-Lopez M. Anosmia in COVID-19 could be associated with long-term deficits in the consolidation of procedural and verbal declarative memories. Frontiers in Neuroscience 2022;16 View
  7. Bendella Z, Widmann C, Layer J, Layer Y, Haase R, Sauer M, Bieler L, Lehnen N, Paech D, Heneka M, Radbruch A, Schmeel F. Brain Volume Changes after COVID-19 Compared to Healthy Controls by Artificial Intelligence-Based MRI Volumetry. Diagnostics 2023;13(10):1716 View
  8. Nouraeinejad A. The functional and structural changes in the hippocampus of COVID-19 patients. Acta Neurologica Belgica 2023;123(4):1247 View
  9. Brandes L, Orme D, Bermeo-Ovalle A, Sierra Morales F. Clinical and diagnostic features of long-COVID patients presenting with neurologic symptoms in Chicago. Journal of Neural Transmission 2024;131(8):961 View
  10. Capelli S, Arrigoni A, Napolitano A, Pezzetti G, Remuzzi A, Zangari R, Lorini F, Sessa M, Caroli A, Gerevini S. MRI evidence of gray matter loss in COVID‐19 patients with cognitive and olfactory disorders. Annals of Clinical and Translational Neurology 2024;11(9):2457 View